With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1435-55-8,Hydroquinidine,as a common compound, the synthetic route is as follows.
EXAMPLE 23 Synthesis of Methylphenylcarbamoyl dihydroquinidine (MPC-DHQD) Dihydroquinidine (1.4 g, 4.3 mmol, 1 eq) was dissolved in 15 ml of CH2 Cl2 under nitrogen atmosphere in a 3-necked 100 ml round bottom flask. At room temperature, 2 ml of triethylamine (14.4 mmol, 3.3 eq) was added to the solution and stirred for 30 minutes. N-methyl-N-phenylcarbamoyl chloride (1.6 g, 9.4 mmol, 2.2 eq) was dissolved in 6 ml CH2 Cl2 and added to the reaction mixture dropwise via an addition funnel. The reaction mixture was stirred under N2 for three days before reaching reaction completion. 50 ml of 2N NaOH were added, and the phases were separated. The CH2 Cl2 layer was saved, and the aqueous phase was extracted with 50 ml of CH2 Cl2. The CH2 Cl2 phases were combined and dried over MgSO4 before being concentrated down to afford a gummy pink material. Purification via flash chromatography (silica gel, 95.5 EtOAc/Et3 N, v/v) afforded a yellow material which was then crystallized from CH3 CN to obtain white starlike crystals (1.27 g, 65% yield). Characterization: mp. 119-120 C. High resolution mass spec; calculated molecular mass–459.25217 amu, found–459.2519 amu. 1 H NMR (300 MHz, CDCl3 with TMS); 8.7 delta (d, 1H), 8.0 delta (d,1H), 7.2-7.4 delta (m, 7H) 6.4 delta (d, 1H), 3.8 delta (s,3H), 3.3 delta (s,3H), 3.1 delta (1H), 2.8 delta (q, 1H), 2.6 delta (m, 3H), 1.7 delta (s,2H), 1.3-1.4 delta (m7H), 0.9 delta (t, 3H). 13 C NMR (75 MHz, CDCl3 with TMS): 12.1 delta, 23.9 delta, 25.3 delta, 26.2 delta, 27.3 delta, 37.5 delta, 38.2 delta, 49.8 delta, 50.7 delta, 55.5 delta, 59.7 delta, 75.6 delta, 75.6 delta, 101.8 delta, 119.1 delta, 121.8 delta, 126.3 delta, 126.7 delta, 127.3 delta, 129.1 delta, 131.7, delta143.1 delta, 144.7 delta, 144.9 delta, 147.5 delta, 152.1 delta, 154.8 delta, 157.7 delta.
1435-55-8 Hydroquinidine 16401293, acatalyst-ligand compound, is more and more widely used in various.
Reference£º
Patent; Massachusetts Institute of Technology; US5227543; (1993); A;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI